Company Name: VOQUZ Labs AG ISIN: DE000A3CSTW4   Reason for the research: Update Recommendation: BUY from: 30.09.2024 Target price: EUR 22.00 Last rating change: Analyst: Philipp Sennewald Final H1 in line with prelims; Guidance confirmed Topic: On Friday, VOQUZ Labs released its final H1 ’24 report, in line with the prelim [ … ]

Company Name: VOQUZ Labs AG ISIN: DE000A3CSTW4   Reason for the research: Update Recommendation: BUY from: 15.08.2024 Target price: EUR 22.00 Last rating change: Analyst: Philipp Sennewald H1 prelims display strong yoy improvements; chg. Topic: VOQUZ Labs released preliminary H1 results, which show significant improvements in top [ … ]

Strong momentum as S/4HANA effect should become visible We hosted a digital roadshow with VOQUZ Labs CEO Martin Kögel, which provided valuable insights into the investment case. Here are the takeaways: Current trading remains on a strong level after we already saw a pick-up in demand in H2 ’23 (+14% sales vs +3% in H1) as Mr. K&oum [ … ]

Huge potential from promising PwC partnership // chg. On Wednesday, VOQUZ Labs announced a strategic partnership with PwC Solutions Germany for the marketing of remQ, the company’s business transaction monitoring and auditing software for SAP customers. In detail: PwC will offer its client base in Germany the establishment of a digitali [ … ]

FY prelims: Strong H2 & promising outlook / chg. est & PT Topic: VOQUZ Labs announced preliminary FY ’23, indicating a strong sequential recovery in H2 regarding both, top-line growth and profitability. Management also issued a promising outlook for the coming year. In detail: H2 sales increased by 16% yoy to € 3.4m (eNuW:  [ … ]

Reassuring order intake and strong trading momentum Yesterday, VOQUZ published reassuring 2023 order intake figures, pointing towards improved operations in the second half of the year. Total order intake increased by 11.5% yoy to € 5.5m with recurring orders accounting for a solid 58% (€ 3.2m). The share of product related sales sl [ … ]